OR WAIT null SECS
August 09, 2021
FDA has approved the intravenous medication Nexviazyme for treatment of Pompe Disease.
AGC Biologics has acquired Novartis’ Longmont, Colorado, manufacturing facility for the commercial production of cell and gene therapies.
The guidance aids in the development, validation, and use of near infrared-based analytical procedures.
August 06, 2021
Syntec receives warning letter where FDA finds deviations from CGMP for APIs.
BeiGene plans to build a new campus for R&D and commercial-scale biopharmaceutical manufacturing in Hopewell, NJ.
Novavax and European Commission have finalized an agreement to purchase up to 200 million doses of a COVID-19 vaccine.
Metrics Contract Services announces the completion of a $10 million expansion to their Greenville, NC facilities.
Catalent finalizes their acquisition of iPSC developer and manufacturer RheinCell Therapeutics.
Syngene International appoints two US-based executives to senior level positions.
August 05, 2021
TriRx continues to expand its manufacturing capabilities with the acquisition of the Elanco Animal Health Facility in Shawnee, Kansas.